Diabetes treatment is constantly progressing, with new therapeutic options appearing to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the https://safasyjj117114.homewikia.com/11974046/emerging_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment